• AcuCort published a replay of its Oct. 13 capital markets day presentation focused on international expansion in Europe and the U.S.
• Europe strategy centers on a commercial deal with Glenmark Pharmaceuticals covering six markets, with launches planned in 2027.
• U.S. plan targets preparation for an NDA filing for Zeqmelit.
• Presentation replay: https://youtu.be/nsS0GzikvFY

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcuCort AB published the original content used to generate this news brief via Cision (Ref. ID: 202610140230BITN____UKPR__SV_20261013-BIT-3030-0) on October 14, 2026, and is solely responsible for the information contained therein.